[Saiding Design Hengyi Coal to Ethylene Glycol Industrial Park Project Starts Constructio]The design and construction of the Hengyi 2.4 million ton coal to ethylene glycol industrial park project with a total investment of 25.7 billion yuan has started, with Saiding Design undertaking the core design tasks. The project is located in Turpan Coal based New Materials Circular Industry Park, covering an area of 2.5375 million square meters with a construction period of 36 months. It will use advanced technology to transform local brown coal resources. After being put into operation, the annual production capacity of the project ranks first in the world, which can meet 60% of the ethylene glycol demand of Hengyi Group, drive employment of over 10000 people, build an integrated industrial chain of "coal ethylene glycol polyester", and help Xinjiang's new industrialization and green low-carbon developmen.Editor/Bian Wenjun
On January 10, 2026, CATL's "Ningjia Service" Middle East's first experience center was opened in Riyadh, Saudi Arabia, which is also its largest overseas new energy aftermarket service facility. The center covers an area of over 7000 square meters and provides full lifecycle services such as battery diagnosis, maintenance, and recycling, covering seven major categories including passenger cars and energy storage systems, and is suitable for the high-temperature sand and dust environment in the Middle East. Relying on a localized certification team and a global spare parts network, it will radiate to countries such as the United Arab Emirates and Qatar, helping Saudi Arabia's "2030 Vision" and injecting momentum into the energy transformation of the Middle East.Editor/Bian Wenjun
On January 8, 2026, Saudi Basic Industries Corporation (SABIC) announced the sale of two major assets for 6.6 billion yuan (950 million US dollars), selling its European petrochemical business to Aequita for 500 million US dollars and its European and American engineering plastics business to Mutares for 450 million US dollars. The sale of assets covers multiple countries' pharmaceutical production bases and various polymer facilities, aiming to divest non core businesses, alleviate high cost pressures in Europe, concentrate resources on high profit areas and growth markets such as China, and optimize capital returns and cash flow.Editor/Bian Wenjun